Bright Uro's mission is to transform care of lower urinary tract symptoms (LUTS) with its innovative technology that is poised to disrupt outdated urodynamics approaches. The Company's investigational Glean™ Urodynamics System is designed to enable wireless, catheter-free urodynamics monitoring, with the ultimate goal of improving patient comfort and clinical outcomes. F
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/30/23 | $23,000,000 | Series A |
Laborie Medical Technologies | undisclosed |
| 10/31/24 | $32,000,000 | Series A |
Freepoint Capital Group Laborie Medical Technologies Laurelin Investors University of California | undisclosed |
